NWBO — Northwest Biotherapeutics Share News
0.000.00%
Last trade - 00:00- $258.75m
- $320.52m
- $1.38m
Brief: Northwest Biotherapeutics Provides Update On Final Preparations For Marketing Authorization Application
Brief: Northwest Biotherapeutics Provides Update On Near Term Plans For Submission Of Marketing Authorization Application
Brief: Northwest Biotherapeutics And Advent Bioservices Announce Receipt Of License For Commercial Manufacturing At Sawston, U.K. Facility
Brief: Northwest Biotherapeutics Announces That It Has No Banking Relationship With SVB
RCS - Cohen Milstein - Northwest Bio Files Market Manipulation Lawsuit
Brief: NW Bio Moves Forward With SEC Settlement
Brief: Nw Bio Announces Non-Dilutive Funding Of About $47.3 Mln
Brief: NW Bio reaches agreement with convertible note holders
Brief: NW bio announces lifting of clinical hold on DCVax-l phase III trial by FDA
Brief: Northwest Biotherapeutics provides update about phase 3 trial of Dcvax-L
Brief: Northwest Biotherapeutics to voluntarily delist from Nasdaq
Brief: Northwest Biotherapeutics files for non-timely 10-Q
Brief: Northwest Biotherapeutics Inc announces registered direct offering
Brief: Northwest Biotherapeutics enters letter agreement with Cognate Bioservices
Brief: Northwest Biotherapeutics files for mixed shelf offering
Brief: Northwest Biotherapeutics said Nasdaq accepts NW Bio Remediation Plan
Brief: Northwest Biotherapeutics plans to use proceeds of offering for initiating Phase II clinical trials
Brief: Northwest Biotherapeutics says will sell to investors about 7.4 mln shares at 50 cents per share
Brief: NW Bio announces scientific advisory board